ODC1 and colorectal carcinoma: Based on this, the combined blocking of ODC and eukaryotic translation initiation factor 5A (eIF5A) can effectively inhibit c-MYC and produce a synergistic anti-tumor effect in CRC (Coni et al., 2023).